Leukocyte telomere length is associated with complications of Type 2 diabetes mellitus

R. Testa, F. Olivieri, C. Sirolla, L. Spazzafumo, M. R. Rippo, M. Marra, A. R. Bonfigli, A. Ceriello, R. Antonicelli, C. Franceschi, C. Castellucci, I. Testa, A. D. Procopio

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Objective: The key goal of diabetes management is to prevent complications. While the patho-physiological mechanisms responsible for diabetes complications have been extensively studied, at present it is impossible to predict which patient with diabetes could develop complications. In recent years, the role of leukocyte telomere length in the pathogenesis of cardiovascular disease and Type2 diabetes has been investigated. However, studies aiming to investigate the role of telomeres in the development and progression of Type2 diabetes, as well as diabetic complications, are still lacking. As a consequence, this study aimed to verify whether leukocyte telomere length is associated with the presence and the number of diabetic complications in a sample of patients with Type2 diabetes. Methods This is a cross-sectional study. Nine hundred and one subjects were enrolled, including 501 patients with Type2 diabetes, of whom 284 had at least one complication and 217 were without complications, and 400 control subjects. Leukocyte telomere length was measured by quantitative real-time PCR. Results Patients with diabetes complications had significantly shorter leukocyte telomere length than both patients without diabetes complications and healthy control subjects. Moreover, among patients with diabetes complications, leukocyte telomere length became significantly and gradually shorter with the increasing number of diabetes complications. The magnitude of the effect of the decrease of the abundance of telomeric template vs. a single-copy gene length (T/S ratio) on complications is described by the estimated odds ratio OR=5.44 (95%CI 3.52-8.42). Conclusions The results of the study support the hypothesis that telomere attrition may be a marker associated with the presence and the number of diabetic complications.

Original languageEnglish
Pages (from-to)1388-1394
Number of pages7
JournalDiabetic Medicine
Volume28
Issue number11
DOIs
Publication statusPublished - Nov 2011

Fingerprint

Telomere
Diabetes Complications
Type 2 Diabetes Mellitus
Leukocytes
Real-Time Polymerase Chain Reaction
Healthy Volunteers
Cardiovascular Diseases
Cross-Sectional Studies
Odds Ratio

Keywords

  • Diabetes complications
  • Telomeres

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Leukocyte telomere length is associated with complications of Type 2 diabetes mellitus. / Testa, R.; Olivieri, F.; Sirolla, C.; Spazzafumo, L.; Rippo, M. R.; Marra, M.; Bonfigli, A. R.; Ceriello, A.; Antonicelli, R.; Franceschi, C.; Castellucci, C.; Testa, I.; Procopio, A. D.

In: Diabetic Medicine, Vol. 28, No. 11, 11.2011, p. 1388-1394.

Research output: Contribution to journalArticle

@article{432d74680d224941846b518e18a89b2b,
title = "Leukocyte telomere length is associated with complications of Type 2 diabetes mellitus",
abstract = "Objective: The key goal of diabetes management is to prevent complications. While the patho-physiological mechanisms responsible for diabetes complications have been extensively studied, at present it is impossible to predict which patient with diabetes could develop complications. In recent years, the role of leukocyte telomere length in the pathogenesis of cardiovascular disease and Type2 diabetes has been investigated. However, studies aiming to investigate the role of telomeres in the development and progression of Type2 diabetes, as well as diabetic complications, are still lacking. As a consequence, this study aimed to verify whether leukocyte telomere length is associated with the presence and the number of diabetic complications in a sample of patients with Type2 diabetes. Methods This is a cross-sectional study. Nine hundred and one subjects were enrolled, including 501 patients with Type2 diabetes, of whom 284 had at least one complication and 217 were without complications, and 400 control subjects. Leukocyte telomere length was measured by quantitative real-time PCR. Results Patients with diabetes complications had significantly shorter leukocyte telomere length than both patients without diabetes complications and healthy control subjects. Moreover, among patients with diabetes complications, leukocyte telomere length became significantly and gradually shorter with the increasing number of diabetes complications. The magnitude of the effect of the decrease of the abundance of telomeric template vs. a single-copy gene length (T/S ratio) on complications is described by the estimated odds ratio OR=5.44 (95{\%}CI 3.52-8.42). Conclusions The results of the study support the hypothesis that telomere attrition may be a marker associated with the presence and the number of diabetic complications.",
keywords = "Diabetes complications, Telomeres",
author = "R. Testa and F. Olivieri and C. Sirolla and L. Spazzafumo and Rippo, {M. R.} and M. Marra and Bonfigli, {A. R.} and A. Ceriello and R. Antonicelli and C. Franceschi and C. Castellucci and I. Testa and Procopio, {A. D.}",
year = "2011",
month = "11",
doi = "10.1111/j.1464-5491.2011.03370.x",
language = "English",
volume = "28",
pages = "1388--1394",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Leukocyte telomere length is associated with complications of Type 2 diabetes mellitus

AU - Testa, R.

AU - Olivieri, F.

AU - Sirolla, C.

AU - Spazzafumo, L.

AU - Rippo, M. R.

AU - Marra, M.

AU - Bonfigli, A. R.

AU - Ceriello, A.

AU - Antonicelli, R.

AU - Franceschi, C.

AU - Castellucci, C.

AU - Testa, I.

AU - Procopio, A. D.

PY - 2011/11

Y1 - 2011/11

N2 - Objective: The key goal of diabetes management is to prevent complications. While the patho-physiological mechanisms responsible for diabetes complications have been extensively studied, at present it is impossible to predict which patient with diabetes could develop complications. In recent years, the role of leukocyte telomere length in the pathogenesis of cardiovascular disease and Type2 diabetes has been investigated. However, studies aiming to investigate the role of telomeres in the development and progression of Type2 diabetes, as well as diabetic complications, are still lacking. As a consequence, this study aimed to verify whether leukocyte telomere length is associated with the presence and the number of diabetic complications in a sample of patients with Type2 diabetes. Methods This is a cross-sectional study. Nine hundred and one subjects were enrolled, including 501 patients with Type2 diabetes, of whom 284 had at least one complication and 217 were without complications, and 400 control subjects. Leukocyte telomere length was measured by quantitative real-time PCR. Results Patients with diabetes complications had significantly shorter leukocyte telomere length than both patients without diabetes complications and healthy control subjects. Moreover, among patients with diabetes complications, leukocyte telomere length became significantly and gradually shorter with the increasing number of diabetes complications. The magnitude of the effect of the decrease of the abundance of telomeric template vs. a single-copy gene length (T/S ratio) on complications is described by the estimated odds ratio OR=5.44 (95%CI 3.52-8.42). Conclusions The results of the study support the hypothesis that telomere attrition may be a marker associated with the presence and the number of diabetic complications.

AB - Objective: The key goal of diabetes management is to prevent complications. While the patho-physiological mechanisms responsible for diabetes complications have been extensively studied, at present it is impossible to predict which patient with diabetes could develop complications. In recent years, the role of leukocyte telomere length in the pathogenesis of cardiovascular disease and Type2 diabetes has been investigated. However, studies aiming to investigate the role of telomeres in the development and progression of Type2 diabetes, as well as diabetic complications, are still lacking. As a consequence, this study aimed to verify whether leukocyte telomere length is associated with the presence and the number of diabetic complications in a sample of patients with Type2 diabetes. Methods This is a cross-sectional study. Nine hundred and one subjects were enrolled, including 501 patients with Type2 diabetes, of whom 284 had at least one complication and 217 were without complications, and 400 control subjects. Leukocyte telomere length was measured by quantitative real-time PCR. Results Patients with diabetes complications had significantly shorter leukocyte telomere length than both patients without diabetes complications and healthy control subjects. Moreover, among patients with diabetes complications, leukocyte telomere length became significantly and gradually shorter with the increasing number of diabetes complications. The magnitude of the effect of the decrease of the abundance of telomeric template vs. a single-copy gene length (T/S ratio) on complications is described by the estimated odds ratio OR=5.44 (95%CI 3.52-8.42). Conclusions The results of the study support the hypothesis that telomere attrition may be a marker associated with the presence and the number of diabetic complications.

KW - Diabetes complications

KW - Telomeres

UR - http://www.scopus.com/inward/record.url?scp=80054699397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054699397&partnerID=8YFLogxK

U2 - 10.1111/j.1464-5491.2011.03370.x

DO - 10.1111/j.1464-5491.2011.03370.x

M3 - Article

C2 - 21692845

AN - SCOPUS:80054699397

VL - 28

SP - 1388

EP - 1394

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 11

ER -